A detailed history of Rhumbline Advisers transactions in Artivion, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 118,836 shares of AORT stock, worth $3.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
118,836
Previous 122,687 3.14%
Holding current value
$3.45 Million
Previous $2.6 Million 17.41%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

SELL
$19.62 - $25.65 $75,556 - $98,778
-3,851 Reduced 3.14%
118,836 $3.05 Million
Q1 2024

May 09, 2024

SELL
$16.7 - $21.63 $5,627 - $7,289
-337 Reduced 0.27%
122,687 $2.6 Million
Q4 2023

Feb 08, 2024

SELL
$12.33 - $18.83 $57,766 - $88,218
-4,685 Reduced 3.67%
123,024 $2.2 Million
Q3 2023

Nov 09, 2023

SELL
$14.82 - $17.52 $40,043 - $47,339
-2,702 Reduced 2.07%
127,709 $1.94 Million
Q2 2023

Aug 08, 2023

BUY
$12.78 - $17.23 $74,558 - $100,519
5,834 Added 4.68%
130,411 $2.24 Million
Q1 2023

May 11, 2023

BUY
$11.74 - $14.12 $68,596 - $82,503
5,843 Added 4.92%
124,577 $1.63 Million
Q4 2022

Feb 14, 2023

BUY
$10.01 - $13.9 $28,358 - $39,378
2,833 Added 2.44%
118,734 $1.44 Million
Q3 2022

Nov 10, 2022

BUY
$13.31 - $23.25 $70,090 - $122,434
5,266 Added 4.76%
115,901 $1.6 Million
Q2 2022

Aug 11, 2022

BUY
$15.73 - $22.91 $73,789 - $107,470
4,691 Added 4.43%
110,635 $2.09 Million
Q1 2022

May 12, 2022

BUY
$16.95 - $21.74 $71,427 - $91,612
4,214 Added 4.14%
105,944 $2.27 Million
Q4 2021

Feb 10, 2022

BUY
$17.19 - $22.84 $60,474 - $80,351
3,518 Added 3.58%
101,730 $2.07 Million
Q3 2021

Nov 12, 2021

SELL
$22.29 - $28.7 $315,158 - $405,789
-14,139 Reduced 12.58%
98,212 $2.19 Million
Q2 2021

Aug 05, 2021

SELL
$22.32 - $32.07 $113,898 - $163,653
-5,103 Reduced 4.34%
112,351 $3.19 Million
Q1 2021

May 06, 2021

BUY
$22.07 - $26.31 $49,348 - $58,829
2,236 Added 1.94%
117,454 $2.65 Million
Q4 2020

Feb 10, 2021

BUY
$16.76 - $23.74 $111,085 - $157,348
6,628 Added 6.1%
115,218 $2.72 Million
Q3 2020

Nov 12, 2020

SELL
$16.35 - $21.4 $98,230 - $128,571
-6,008 Reduced 5.24%
108,590 $2.01 Million
Q2 2020

Aug 13, 2020

SELL
$16.34 - $25.24 $77,794 - $120,167
-4,761 Reduced 3.99%
114,598 $2.2 Million
Q1 2020

May 06, 2020

BUY
$14.66 - $30.57 $39,464 - $82,294
2,692 Added 2.31%
119,359 $2.02 Million
Q4 2019

Feb 05, 2020

BUY
$22.45 - $27.09 $143,545 - $173,213
6,394 Added 5.8%
116,667 $3.16 Million
Q3 2019

Oct 23, 2019

BUY
$25.98 - $30.8 $185,808 - $220,281
7,152 Added 6.94%
110,273 $2.99 Million
Q2 2019

Aug 14, 2019

BUY
$27.55 - $32.39 $73,420 - $86,319
2,665 Added 2.65%
103,121 $3.09 Million
Q1 2019

May 01, 2019

BUY
$25.85 - $30.47 $15,820 - $18,647
612 Added 0.61%
100,456 $2.93 Million
Q4 2018

Jan 31, 2019

BUY
$25.76 - $34.03 $492,969 - $651,232
19,137 Added 23.71%
99,844 $2.83 Million
Q3 2018

Nov 07, 2018

SELL
$28.6 - $35.75 $35,521 - $44,401
-1,242 Reduced 1.52%
80,707 $2.84 Million
Q2 2018

Aug 06, 2018

BUY
$19.4 - $29.35 $113,645 - $171,932
5,858 Added 7.7%
81,949 $2.28 Million
Q1 2018

May 02, 2018

BUY
$16.85 - $22.1 $26,892 - $35,271
1,596 Added 2.14%
76,091 $1.53 Million
Q4 2017

Feb 09, 2018

BUY
$18.65 - $23.85 $221,860 - $283,719
11,896 Added 19.0%
74,495 $1.43 Million
Q3 2017

Nov 06, 2017

BUY
$18.85 - $23.05 $1.18 Million - $1.44 Million
62,599
62,599 $1.42 Million

Others Institutions Holding AORT

About ARTIVION, INC.


  • Ticker AORT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 40,316,100
  • Market Cap $1.17B
  • Description
  • Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...
More about AORT
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.